EUVIMEDEUVIMED entdecken
Crossref

Targeting VDAC and Autophagy in Head and Neck Oral Squamous Carcinoma: Synergy of Itraconazole and Hydroxychloroquine

Javiera Carrasco-Rojas, Ivonne Olmedo, Daniela Martínez, Sebastián Yévenes iD, Rodrigo López-Muñoz, Jennifer Faúndez, Mabel Catalán, Karla Gutiérrez, Alfredo Molina-Berríos, José A Jara

Oral Diseases · 2026-09 · 32 (9) · 2695-2712

DOI: 10.1111/odi.70374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 10.06.2026. Verfasst von Javiera Carrasco-Rojas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, Universidad de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Hydroxychloroquine, Itraconazole, Autophagy, Mouth Neoplasms. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Oral squamous cell carcinoma (OSCC), a common subtype of head and neck cancer (HNSC), impairs essential functions such as breathing, swallowing, and speech. This study aimed to evaluate the therapeutic potential of targeting mitochondrial pathways via inhibition of Voltage‐Dependent Anionic Channel 1 (VDAC1) using itraconazole (ITRA) and to assess the synergistic effect of combining VDAC1 inhibition with autophagy inhibition using hydroxychloroquine (HCQ).

Methods

The effects of ITRA, HCQ, and their combinations with cisplatin were tested in various HNSC models, including monolayer cultures, hypoxic conditions, 3D spheroids, and an in vivo xenograft model. The study also examined the role of the VDAC1‐Hexokinase‐II complex and the impact of autophagy under metabolic stress.

Results

ITRA alone showed limited cytotoxicity, but its combination with HCQ significantly enhanced antitumoral activity. Synergistic effects were observed with HCQ + ITRA, HCQ + cisplatin, and ITRA + cisplatin in all in vitro models. In vivo, HCQ alone and in combination with ITRA reduced tumor growth without adverse effects.

Conclusions

Taken together, these findings support itraconazole as a promising candidate for further in vivo and clinical investigation in selected oral cancers, including HNSCC and OSCC. Nevertheless, the definition of clinical treatment schedules will require additional comprehensive pharmacokinetic, toxicological, and clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxychloroquineItraconazoleAutophagyMouth NeoplasmsCarcinoma, Squamous CellAntineoplastic AgentsSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsVoltage-Dependent Anion ChannelsHumansAnimalsCisplatinDrug SynergismMiceCell Line, TumorXenograft Model Antitumor AssaysVoltage-Dependent Anion Channel 1

Stichwörter der Autor:innen

chemotherapycisplatindrug combinationshead and neck cancerhydroxychloroquinehypoxic culturesitraconazoleoral canceroral cancer xenograft modelspheroids cultures

Substanzen

HydroxychloroquineItraconazoleCisplatinAntineoplastic AgentsVDAC1 protein, humanVoltage-Dependent Anion ChannelsVoltage-Dependent Anion Channel 1

Autor:innen und Institutionen

  • Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
  • Institute for Research in Biomedical Sciences, Medicine Faculty, Universidad de Chile, Santiago, Chile.
  • Instituto de Farmacología y morfofisiología, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile.

ORCID-Profile: Sebastián Yévenes

Förderung

  • Fondo Nacional de Desarrollo Científico y Tecnológico

Zitieren

APA

Carrasco-Rojas, J., Olmedo, I., Martínez, D., Yévenes, S., López-Muñoz, R., Faúndez, J., Catalán, M., Gutiérrez, K., Molina-Berríos, A., & Jara, J. A. (2026). Targeting VDAC and Autophagy in Head and Neck Oral Squamous Carcinoma: Synergy of Itraconazole and Hydroxychloroquine. Oral Diseases, 32(9), 2695-2712. https://doi.org/10.1111/odi.70374

Vancouver

Carrasco-Rojas J, Olmedo I, Martínez D, Yévenes S, López-Muñoz R, Faúndez J, et al. Targeting VDAC and Autophagy in Head and Neck Oral Squamous Carcinoma: Synergy of Itraconazole and Hydroxychloroquine. Oral Diseases. 2026;32(9):2695-2712. doi:10.1111/odi.70374

BibTeX
@article{CarrascoRojas2026,
  author = {Carrasco-Rojas, Javiera and Olmedo, Ivonne and Martínez, Daniela and Yévenes, Sebastián and López-Muñoz, Rodrigo and Faúndez, Jennifer and Catalán, Mabel and Gutiérrez, Karla and Molina-Berríos, Alfredo and Jara, José A},
  title = {Targeting VDAC and Autophagy in Head and Neck Oral Squamous Carcinoma: Synergy of Itraconazole and Hydroxychloroquine},
  journal = {Oral Diseases},
  year = {2026},
  volume = {32},
  number = {9},
  pages = {2695--2712},
  doi = {10.1111/odi.70374}
}
Kostenlos starten →